Hi Ezq
”….PromarkerD test in predicting diabetic kidney disease was “published”today in journal PLOS ONE…”
I don’t recall being previously advised that it was actually published in PLOS ONE a highly regarded peer-reviewed open access journal.
This exposure is phenomenal.
The publication is quite an in-depth look at PromarkerD & available for all to read.
Ann: Clinical Utility Study demonstrates PromarkerD test benefits, page-6
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
62.0¢ |
Change
-0.010(1.59%) |
Mkt cap ! $81.22M | |||
| Open | High | Low | Value | Volume |
| 63.0¢ | 63.0¢ | 55.0¢ | $571.7K | 964.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | 59.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.0¢ | 9013 | 1 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |